News & Updates

New drug applications approved by US FDA as of 16-28 February 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

The use of wearable devices is feasible for the automated seizure detection in the home environment, leading to better care outcomes, such as fewer seizure-related injuries and more accurate seizure diaries, according to a recent study.

Endoscopic resection (ER) is a safe and effective management approach for oesophageal granular cell tumours (GCT), yielding high rates of procedural success and low long-term mortality and complications, a recent study has found.

Engaging in moderate- or high-intensity aerobic exercises for at least 6 weeks may positively modulate the composition of gut microbiota in patients with metabolic diseases, as shown in a study.

A resistance exercise-training program is enough to yield gains in muscle strength and functional capacity in paediatric cystic fibrosis (CF) patients with mild-to-moderate pulmonary impairment, a study has found. Meanwhile, the addition of neuromuscular electrical stimulation (NMES) does not appear to provide extra benefit.

For older adults, the efficacy of influenza vaccination is associated with vaccine-circulating strain matching, as reported in a study. If the strains are all matched, the vaccine can reduce the risk of hospitalization for community-acquired pneumonia by up to 28 percent.

Eptinezumab reduces migraine days for both episodic and chronic migraine patients, and the drug’s efficacy and safety profile are independent of age, sex, and body mass index, as shown in a study.